Big data in IBD: a look into the future

Pablo Olivera, Silvio Danese, Nicolas Jay, Gioacchino Natoli, Laurent Peyrin-Biroulet

Research output: Contribution to journalReview article

Abstract

Big data methodologies, made possible with the increasing generation and availability of digital data and enhanced analytical capabilities, have produced new insights to improve outcomes in many disciplines. Application of big data in the health-care sector is in its early stages, although the potential for leveraging underutilized data to gain a better understanding of disease and improve quality of care is enormous. Owing to the intrinsic characteristics of inflammatory bowel disease (IBD) and the management dilemmas that it imposes, the implementation of big data research strategies not only can complement current research efforts but also could represent the only way to disentangle the complexity of the disease. In this Review, we explore important potential applications of big data in IBD research, including predictive models of disease course and response to therapy, characterization of disease heterogeneity, drug safety and development, precision medicine and cost-effectiveness of care. We also discuss the strengths and limitations of potential data sources that big data analytics could draw from in the field of IBD, including electronic health records, clinical trial data, e-health applications and genomic, transcriptomic, proteomic, metabolomic and microbiomic data.

Original languageEnglish
Pages (from-to)312-321
Number of pages10
JournalNature Reviews Gastroenterology and Hepatology
Volume16
Issue number5
DOIs
Publication statusPublished - May 2019

    Fingerprint

Keywords

  • Big Data
  • Clinical Decision-Making/methods
  • Cost-Benefit Analysis
  • Humans
  • Inflammatory Bowel Diseases/diagnosis
  • Precision Medicine/economics
  • Prognosis
  • United States

Cite this